RU93004984A - PHARMACEUTICAL COMPOSITION BASED ON 5 (2-CHLOR-1-HYDROXYETHYLCH) -4-METHYL-THIASOLE, APPLICATION 5- (2-CHLOR-1-HYDROXYETHYL) -4-METHYL-TIAZOLE FOR TREATMENT, SPECIFICATION: TYPE HYDROXYETHYL TYPE -1-hydroxyethyl) -4-methylthiazole - Google Patents
PHARMACEUTICAL COMPOSITION BASED ON 5 (2-CHLOR-1-HYDROXYETHYLCH) -4-METHYL-THIASOLE, APPLICATION 5- (2-CHLOR-1-HYDROXYETHYL) -4-METHYL-TIAZOLE FOR TREATMENT, SPECIFICATION: TYPE HYDROXYETHYL TYPE -1-hydroxyethyl) -4-methylthiazoleInfo
- Publication number
- RU93004984A RU93004984A RU93004984/14A RU93004984A RU93004984A RU 93004984 A RU93004984 A RU 93004984A RU 93004984/14 A RU93004984/14 A RU 93004984/14A RU 93004984 A RU93004984 A RU 93004984A RU 93004984 A RU93004984 A RU 93004984A
- Authority
- RU
- Russia
- Prior art keywords
- hydroxyethyl
- chlor
- methyl
- type
- methylthiazole
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title claims 2
- -1 2-CHLOR-1-HYDROXYETHYL Chemical class 0.000 title 1
- 125000000954 2-hydroxyethyl group Chemical group [H]C([*])([H])C([H])([H])O[H] 0.000 title 1
- DEFWCWPULGCHIU-UHFFFAOYSA-N 2-chloro-1-(4-methyl-1,3-thiazol-2-yl)ethanol Chemical compound CC1=CSC(C(O)CCl)=N1 DEFWCWPULGCHIU-UHFFFAOYSA-N 0.000 claims 1
- 230000003287 optical Effects 0.000 claims 1
- 150000003839 salts Chemical class 0.000 claims 1
- 239000011780 sodium chloride Substances 0.000 claims 1
- 239000012453 solvate Substances 0.000 claims 1
Claims (1)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9002659-2 | 1990-07-15 | ||
SE9002659A SE9002659D0 (en) | 1990-08-15 | 1990-08-15 | NEW PHARMACEUTICAL FORMULATIONS |
PCT/SE1991/000522 WO1992003134A1 (en) | 1990-08-15 | 1991-08-07 | New pharmaceutical formulations of 5-(2-chloro-1-hydroxyethyl)-4-methylthiazole |
Publications (2)
Publication Number | Publication Date |
---|---|
RU93004984A true RU93004984A (en) | 1995-05-10 |
RU2093155C1 RU2093155C1 (en) | 1997-10-20 |
Family
ID=20380161
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU9193004984A RU2093155C1 (en) | 1990-08-15 | 1991-08-07 | Use of 5-(2-chloro-1-hydroxyethyl)-4-methylthiazole for decrease of neuron damage, suppression of convulse and motor activity decrease |
Country Status (26)
Country | Link |
---|---|
US (1) | US5385921A (en) |
EP (1) | EP0619734B1 (en) |
JP (1) | JP3094077B2 (en) |
AT (1) | ATE164066T1 (en) |
AU (1) | AU657490B2 (en) |
BG (1) | BG97446A (en) |
CA (1) | CA2088775A1 (en) |
CZ (1) | CZ279586B6 (en) |
DE (1) | DE69129126T2 (en) |
DK (1) | DK0619734T3 (en) |
ES (1) | ES2114891T3 (en) |
FI (1) | FI930608A0 (en) |
HU (1) | HUT65821A (en) |
IE (1) | IE912818A1 (en) |
IL (1) | IL99169A (en) |
IS (1) | IS3743A7 (en) |
LT (1) | LT3978B (en) |
LV (1) | LV10921B (en) |
NO (1) | NO303447B1 (en) |
NZ (1) | NZ239329A (en) |
PT (1) | PT98688B (en) |
RO (1) | RO112994B1 (en) |
RU (1) | RU2093155C1 (en) |
SE (1) | SE9002659D0 (en) |
SK (1) | SK8793A3 (en) |
WO (1) | WO1992003134A1 (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE9901658D0 (en) * | 1999-05-06 | 1999-05-06 | Astra Ab | New formulation |
SE9904177D0 (en) * | 1999-11-18 | 1999-11-18 | Astra Ab | Novel compounds |
WO2002083863A2 (en) | 2001-04-17 | 2002-10-24 | Sepracor, Inc. | Thiazole and other heterocyclic ligands and use thereof |
CN103772313B (en) * | 2014-01-02 | 2015-10-14 | 郑桂富 | A kind of synthetic method of 4-methyl-5-(2-hydroxyethyl) thiazole |
CN112262814A (en) * | 2020-10-26 | 2021-01-26 | 宜宾学院 | Chicken raising method by cinnamomum longepaniculatum leaf residue fermentation bed |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2825966A1 (en) * | 1978-06-14 | 1980-01-03 | Basf Ag | ACID GALVANIC NICKEL BATH, WHICH CONTAINS SULFOBETAINE AS A GLOSSY AND LEVELING AGENT |
GB8600783D0 (en) * | 1986-01-14 | 1986-02-19 | Merck Sharp & Dohme | N-methyl-d-aspartate receptor antagonists |
-
1990
- 1990-08-15 SE SE9002659A patent/SE9002659D0/en unknown
-
1991
- 1991-08-07 RO RO93-00194A patent/RO112994B1/en unknown
- 1991-08-07 DK DK91915138T patent/DK0619734T3/en active
- 1991-08-07 EP EP91915138A patent/EP0619734B1/en not_active Expired - Lifetime
- 1991-08-07 SK SK8793A patent/SK8793A3/en unknown
- 1991-08-07 AU AU84092/91A patent/AU657490B2/en not_active Ceased
- 1991-08-07 RU RU9193004984A patent/RU2093155C1/en active
- 1991-08-07 JP JP03514007A patent/JP3094077B2/en not_active Expired - Lifetime
- 1991-08-07 DE DE69129126T patent/DE69129126T2/en not_active Expired - Lifetime
- 1991-08-07 CA CA002088775A patent/CA2088775A1/en not_active Withdrawn
- 1991-08-07 AT AT91915138T patent/ATE164066T1/en not_active IP Right Cessation
- 1991-08-07 CZ CS93166A patent/CZ279586B6/en unknown
- 1991-08-07 ES ES91915138T patent/ES2114891T3/en not_active Expired - Lifetime
- 1991-08-07 WO PCT/SE1991/000522 patent/WO1992003134A1/en active IP Right Grant
- 1991-08-07 HU HU9300388A patent/HUT65821A/en unknown
- 1991-08-09 NZ NZ239329A patent/NZ239329A/en unknown
- 1991-08-09 IE IE281891A patent/IE912818A1/en unknown
- 1991-08-12 IL IL9916991A patent/IL99169A/en active IP Right Grant
- 1991-08-14 PT PT98688A patent/PT98688B/en not_active IP Right Cessation
- 1991-08-14 US US07/744,914 patent/US5385921A/en not_active Expired - Lifetime
- 1991-08-14 IS IS3743A patent/IS3743A7/en unknown
-
1993
- 1993-02-09 NO NO930452A patent/NO303447B1/en not_active IP Right Cessation
- 1993-02-11 FI FI930608A patent/FI930608A0/en unknown
- 1993-02-15 BG BG97446A patent/BG97446A/en unknown
- 1993-08-10 LV LVP-93-1024A patent/LV10921B/en unknown
- 1993-12-30 LT LTIP1714A patent/LT3978B/en not_active IP Right Cessation
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE131048T1 (en) | DRUG. | |
NL300035I2 (en) | Substituted thiazolidinedione derivatives. | |
FI913917A (en) | 3-AMIDOPYRAZOLDERIVAT, FOERFARANDE FOER FRAMSTAELLNING AV DESSA OCH PHARMACEUTICAL COMPOSITION INNEHAOLLANDE DESSA. | |
FI925615A0 (en) | PHARMACEUTICAL COMPOSITION OF THE STABILIZER, SOM INNEHAOLLER EN HMG-COA-REDUKTAS-INHIBITORFOERENING | |
DE69101931D1 (en) | Pharmaceutical composition. | |
DE59002903D1 (en) | 3-AMINO-5-AMINOCARBONYL-1,2,4-TRIAZOLE DERIVATIVES. | |
FI910851A (en) | 3-ARYLCARBONYL-1H-INDOLER ANVAENDBARA SOM THERAPEUTIC AEMNEN. | |
DE69111359D1 (en) | Crosslinkable cellulose derivatives. | |
FI903382A0 (en) | TOPISKT ANBRINGBARA PHARMACEUTICAL PREPARAT. | |
TR27580A (en) | The new 4-benzoylisoxazole derivatives, compositions containing them, processes for their preparation. | |
NZ240378A (en) | Substituted thiazolidinedione derivatives; pharmaceutical compositions, | |
DE69115263D1 (en) | PHARMACEUTICAL COMPOSITIONS. | |
FI923031A0 (en) | 1,4-BIS- (AMINO-HYDROXIALKYLAMINO) - ANTHRACINONER FOR INHIBERING AV PROTEINKIN C. | |
FI890050A (en) | NYA 3,5-DIHYDROXIKARBONSYROR OCH DERAS DERIVAT, FOERFARANDE FOER DERAS FRAMSTAELLNING, DERAS ANVAENDNING SOM LAEKEMEDEL, PHARMACEUTICAL PREPARAT OCH MELLANPRODUKTER. | |
DZ1576A1 (en) | Therapeutic compositions based on 1,2-dithiole-3-thione derivatives. | |
RU93004984A (en) | PHARMACEUTICAL COMPOSITION BASED ON 5 (2-CHLOR-1-HYDROXYETHYLCH) -4-METHYL-THIASOLE, APPLICATION 5- (2-CHLOR-1-HYDROXYETHYL) -4-METHYL-TIAZOLE FOR TREATMENT, SPECIFICATION: TYPE HYDROXYETHYL TYPE -1-hydroxyethyl) -4-methylthiazole | |
DE59104765D1 (en) | Substituted 5-alkoxy-1,2,4-triazol-3- (thi) one. | |
DE69013131D1 (en) | 2- (2-Cyclopropylpyrrolidin-4-ylthio) carbapenem derivatives. | |
SE9002659D0 (en) | NEW PHARMACEUTICAL FORMULATIONS | |
DE69014705D1 (en) | Thiazole derivatives. | |
DE69008019D1 (en) | Benzothiazole derivatives. | |
FI904932A (en) | OPTISKT AKTIVA TIAZETOKINOLIN-3 CARBOXYL SYRADERIVAT, FOERFARANDE FOER DERAS FRAMSTAELLNING OCH DESSA INNEHAOLLANDE PHARMACEUTICAL COMPOSITION. | |
RU93051079A (en) | PHARMACEUTICAL COMPOUNDS, PRODUCTION METHOD, PHARMACEUTICAL COMPOSITION | |
DE69104013D1 (en) | Hexitol derivatives. | |
FI932034A (en) | This 1-azacycloalkander derivative is a pharmaceutical formulation having the same composition as the formulation. |